Rub shoulders with leading experts and industry disruptors at TNW Conference →

The heart of tech

This article was published on May 8, 2013


    Clinical trials startup TrialReach doses up on $3.1m funding led by Octopus Investments

    Clinical trials startup TrialReach doses up on $3.1m funding led by Octopus Investments Image by: PHILIPPE HUGUEN
    Martin Bryant
    Story by

    Martin Bryant

    Founder

    Martin Bryant is founder of Big Revolution, where he helps tech companies refine their proposition and positioning, and develops high-qualit Martin Bryant is founder of Big Revolution, where he helps tech companies refine their proposition and positioning, and develops high-quality, compelling content for them. He previously served in several roles at TNW, including Editor-in-Chief. He left the company in April 2016 for pastures new.

    TrialReach, a startup focused on making clinical trials more accessible for members of the public who may want to take part in them, has today announced a £2 million ( $3.1 million) funding round in order to further develop its product.

    TrialReach is designed to help medical research firms recruit participants for trials. Unlike other medical trial directories that tend to rely on potential candidates going out and looking for them, the startup uses proprietary algorithms, a network of distribution partners, and tracking tools to seek out the most relevant audience for any particular trial. For example, a trial may be promoted via search engines, forums or online patient communities.

    Information about each trial is presented in plain language on a standardized Web page. The startup mainly covers the US and Europe in English, Spanish, French, German, and Italian languages although it also operates in Eastern Europe, the Pacific Rim and South America.

    The funding round has been led by Octopus Investments, with participation from existing investor Amadeus Capital Partners. London, UK-based TrialReach was founded in 2010 and took on its first external investment round the following year. The new money will be used in part to launch new products in the field of clinical trial recruitment.

    Here’s how TrialReach presents itself to the pharmaceutical industry:

    http://www.youtube.com/watch?v=8Zj8kd4eoUM

    Catch up with the latest tech business news at TNW Insider.

    Image credit: AFP / Getty Images